#2571081
an Coiste Slándála Sláinte;
the Health Security Committee (HSC);
an Coiste Slándála Sláinte;
the Health Security Committee (HSC);
An Coiste Slándála Sláinte
Health Security Committee
Bunaítear leis seo an Coiste Slándála Sláinte.
The HSC is hereby established.
A mhéid is féidir, glacfaidh an Coiste Slándála Sláinte a threoir agus a thuairimí de chomhthoil.
As far as possible, the HSC shall adopt its guidance and opinions by consensus.
Glacfaidh an Coiste Slándála Sláinte, trí thromlach dhá thrian dá chomhaltaí, a rialacha nós imeachta.
The HSC shall adopt, by a two-thirds majority of its members, its rules of procedure.
Amhail an Coiste Slándála Sláinte.
Such as the Health Security Committee.
Chomhaontaigh an Coiste Slándála Sláinte an seachtú nuashonrú ar an liosta coiteann, arb é an nuashonrú is déanaí é, an 10 Samhain 2021.
The seventh and latest update of the common list was agreed by the Health Security Committee on 10 November 2021.
Dá réir sin, is gá don Choimisiún plean an Aontais um ghéarchéim sláinte agus paindéim a bhunú, plean a fhormheasfaidh an Coiste Slándála Sláinte.
As such, a Union health crisis and pandemic plan needs to be established by the Commission and approved by the HSC.
Tiocfaidh an Coiste Slándála Sláinte le chéile go tráthrialta agus nuair a bheidh gá leis, arna iarraidh sin don Choimisiún nó do Bhallstát.
The HSC shall meet at regular intervals and whenever the situation requires, at the request of the Commission or a Member State.
Áiritheoidh an Coiste Slándála Sláinte agus an Coimisiún comhairliúchán rialta le saineolaithe sláinte poiblí, eagraíochtaí idirnáisiúnta agus geallsealbhóirí, lena n-áirítear gairmithe cúraim sláinte, ag brath ar íogaireacht an ábhair.
The HSC and the Commission shall ensure regular consultation with public health experts, international organisations and stakeholders, including healthcare professionals, depending on the sensitivity of the subject.
comhar tráthúil idir an Coimisiún, an Chomhairle, na Ballstáit, an Coiste Slándála Sláinte agus gníomhaireachtaí nó comhlachtaí ábhartha an Aontais.
the timely cooperation between the Commission, the Council, the Member States, the HSC and the relevant Union agencies or bodies.
Cuirfidh na Ballstáit an Coimisiún agus an Coiste Slándála Sláinte ar an eolas, gan mhoill, faoi aon athbhreithniú substaintiúil ar a bplean náisiúnta coisc, ullmhachta agus freagartha.
Member States shall also inform, without delay, the Commission and the HSC of any substantial revision of their national prevention, preparedness and response plan.
Féadfaidh an Coiste Slándála Sláinte teachtaireachtaí agus moltaí a ghlacadh maidir le faireachas atá dírithe ar na Ballstáit, ar ECDC agus ar an gCoimisiún.
The HSC may adopt communications and recommendations on surveillance addressed to Member States, the ECDC and the Commission.
Déanfaidh an Coiste Slándála Sláinte agus an Coiste Comhairleach a ngníomhaíochtaí ar bhealach neamhspleách, neamhchlaonta agus trédhearcach agus gníomhóidh siad ar mhaithe le leas an phobail.
The HSC and the Advisory Committee shall carry out their activities in an independent, impartial and transparent manner and shall undertake to act in the public interest.
Beidh san áireamh in inneachar an Tacair Luacha an rogha tástála mire antaiginí mar a liostaítear sa liosta comhchoiteann agus nuashonraithe de thástálacha meara antaiginí COVID-19, arna mbunú ar bhonn Mholadh 2021/C 24/01 ón gComhairle agus a d’aontaigh an Coiste Slándála Sláinte.
The content of the Value Set shall include the selection of rapid antigen test as listed in the common and updated list of COVID-19 rapid antigen tests, established on the basis of Council Recommendation 2021/C 24/01 and agreed by the Health Security Committee.
Chuir an Eilvéis in iúl don Choimisiún freisin nach n-eiseoidh sí deimhnithe tástála idir-inoibritheacha ach amháin i ndáil le tástálacha aimpliúcháin aigéid núicléasaigh nó i ndáil le mearthástálacha antaiginí a liostaítear sa liosta coiteann cothrom le dáta de mhearthástálacha antaigíní COVID-19 arna gcomhaontú ag an Coiste Slándála Sláinte ar bhonn Mholadh ón gComhairle an 21 Eanáir 2021, ar Coiste é a bunaíodh le hAirteagal 17 de Chinneadh Uimh. 1082/2013/AE ó Pharlaimint na hEorpa agus ón gComhairle.
Switzerland also informed the Commission that it will issue interoperable test certificates only for nucleic acid amplification tests or for rapid antigen tests listed in the common and updated list of COVID-19 rapid antigen tests agreed by the Health Security Committee, established by Article 17 of Decision No 1082/2013/EU of the European Parliament and of the Council, on the basis of the Council Recommendation of 21 January 2021.
Beidh san áireamh in inneachar an Tacair Luacha an rogha mearthástála antaiginí mar a liostaítear sa liosta comhchoiteann agus nuashonraithe de mhearthástálacha antaiginí COVID-19, arna mbunú ar bhonn Mholadh 2021/C 24/01 ón gComhairle agus a chomhaontaigh an Coiste Slándála Sláinte.
The content of the value set shall include the selection of rapid antigen test as listed in the common and updated list of COVID-19 rapid antigen tests, established on the basis of Council Recommendation 2021/C 24/01 and agreed by the Health Security Committee.
Chun an tsaorghluaiseacht a éascú, agus chun a áirithiú gur féidir deireadh a chur leis na srianta ar an tsaorghluaiseacht atá i bhfeidhm faoi láthair le linn phaindéim COVID-19 ar mhodh comhordaithe, bunaithe ar an bhfianaise eolaíoch agus an treoir is déanaí a chuireann an Coiste Slándála Sláinte a bunaíodh le hAirteagal 17 de Chinneadh Uimh. 1082/2013/AE ó Pharlaimint na hEorpa agus ón gComhairle, ECDC agus an Ghníomhaireacht Leigheasra Eorpach (EMA) ar fáil, ba cheart deimhniú vacsaínithe idir-inoibritheach a bhunú.
For the purpose of facilitating free movement, and to ensure that restrictions to free movement currently in place during the COVID-19 pandemic can be lifted in a coordinated manner based on the latest scientific evidence and guidance made available by the Health Security Committee established by Article 17 of Decision No 1082/2013/EU of the European Parliament and of the Council, ECDC and the European Medicines Agency (EMA), an interoperable vaccination certificate should be established.
Ar bhonn an Mholta sin, tháinig an Coiste Slándála Sláinte ar chomhaontú, n 18 Feabhra 2021, maidir le liosta comhchoiteann de mhearthástálacha antaiginí COVID-19, rogha de mhearthástálacha antaiginí a dtabharfaidh na Ballstáit aitheantas frithpháirteach dá dtorthaí agus tacar comhchoiteann caighdeánaithe sonraí atá le háireamh i ndeimhnithe tástála COVID-19.
On the basis of that Recommendation, the Health Security Committee agreed, on 18 February 2021, on a common list of COVID-19 rapid antigen tests, a selection of rapid antigen tests for which Member States will mutually recognise their results and a common standardised set of data to be included in COVID-19 test certificates.
An 11 Bealtaine 2021, ghlac an Coiste Slándála Sláinte liosta nuashonraithe de mhearthástálacha antaiginí, liosta lena ndéantar líon na mearthástálacha antaiginí a n-aithnítear go gcomhlíonann siad critéir cháilíochta a mhéadú go dtí 83.
On 11 May 2021, the Health Security Committee adopted an updated list of rapid antigen tests, increasing the number of rapid antigen tests recognised as meeting quality criteria to 83.
I mí na Bealtaine 2021, bhunaigh an Coiste Slándála Sláinte, a bunaíodh le hAirteagal 17 de Chinneadh Uimh. 1082/2013/AE, meitheal theicniúil um thástálacha diagnóiseacha COVID-19, ina dtugtar le chéile saineolaithe ó na Ballstáit agus ón Iorua, mar aon le hionadaithe ón gCoimisiún agus ón Lárionad Eorpach um Ghalair a Chosc agus a Rialú (‘ECDC’).
In May 2021, the Health Security Committee established by Article 17 of Decision No 1082/2013/EU of the European Parliament and of the Council set up a technical working group on COVID-19 diagnostic tests, which brings together experts from the Member States and Norway as well as representatives from the Commission and the European Centre for Disease Prevention and Control (‘ECDC’).
Féadfaidh Ballstát freisin, má iarrtar sin air, deimhnithe téarnaimh dá dtagraítear i bpointe (c) d’Airteagal 3(1) a eisiúint tar éis toradh dearfach a bheith ar mhearthástáil antaiginí atá ar liosta coiteann an Aontais de thástálacha antaiginí COVID-19 a chomhaontaíonn an Coiste Slándála Sláinte agus a dhéanann gairmithe sláinte nó pearsanra tástála oilte.
A Member State may also issue, upon request, certificates of recovery referred to in point (c) of Article 3(1) following a positive result of a rapid antigen test listed in the EU common list of COVID-19 antigen tests agreed by the Health Security Committee carried out by health professionals or by skilled testing personnel.
Dá bhrí sin, is féidir leis na Ballstáit deimhnithe tástála a eisiúint agus, tar éis do Rialachán Tarmligthe (AE) 2022/256 ón gCoimisiún a bheith glactha, deimhnithe téarnaimh a eisiúint ar bhonn na dtástálacha antaiginí a áirítear ar liosta coiteann an Aontais de thástálacha antaiginí COVID-19, ar liosta é a dhéanann an Coiste Slándála Sláinte a chomhaontú mar liosta a chomhlíonann na critéir cháilíochta a leagtar síos agus a thabhairt cothrom le dáta go tráthrialta.
It is now possible for Member States to issue test certificates and, following the adoption of Commission Delegated Regulation (EU) 2022/256, certificates of recovery on the basis of the antigen tests included in the EU common list of COVID-19 antigen tests, as agreed, and regularly updated, by the Health Security Committee and as meeting the established criteria.
“Beidh san áireamh in inneachar an tacair luacha an rogha tástála antaiginí mar a liostaítear sa liosta coiteann agus nuashonraithe de thástálacha antaiginí COVID-19, arna mbunú ar bhonn Mholadh 2021/C 24/01 ón gComhairle agus a chomhaontaigh an Coiste Slándála Sláinte. Déanann an tAirmheán Comhpháirteach Taighde an liosta a choimeád sa Bhunachar Sonraí maidir le Modhanna Tástála agus Feistí Diagnóiseacha In Vitro COVID-19 ag: https://covid-19-diagnostics.jrc.ec.europa.eu/devices/hsc-common-recognition-rat.”.
‘The content of the value set shall include the selection of antigen test as listed in the common and updated list of COVID-19 antigen tests, established on the basis of Council Recommendation 2021/C 24/01 and agreed by the Health Security Committee. The list is maintained by the JRC in the COVID-19 In Vitro Diagnostic Devices and Test Methods Database at: https://covid-19-diagnostics.jrc.ec.europa.eu/devices/hsc-common-recognition-rat’.
Ba cheart, dá bhrí sin, na Ballstáit a bheith in ann deimhnithe tástála agus, tar éis do Rialachán Tarmligthe (AE) 2022/256 ón gCoimisiún a bheith glactha, deimhnithe téarnaimh a eisiúint ar bhonn na dtástálacha antaiginí a áirítear ar liosta coiteann an Aontais de thástálacha antaiginí COVID-19, ar liosta é a dhéanann an Coiste Slándála Sláinte a chomhaontú mar liosta a chomhlíonann na critéir cháilíochta atá leagtha síos agus a nuashonrú go tráthrialta.
It should thus be possible for Member States to issue test certificates and, following the adoption of Commission Delegated Regulation (EU) 2022/256, certificates of recovery on the basis of the antigen tests included in the EU common list of COVID-19 antigen tests agreed, and regularly updated, by the Health Security Committee as meeting the established quality criteria.
Chun éifeachtacht na hullmhachta agus na freagartha i leith bagairtí tromchúiseacha trasteorann ar an tsláinte a mhéadú, ba cheart don Choimisiún, lena n-áirítear, i gcás inarb ábhartha, an tÚdarás Eorpach um Ullmhacht agus Freagairt i dtaca le hÉigeandáilí Sláinte (HERA) a bunaíodh mar sheirbhís de chuid an Choimisiúin le Cinneadh ón gCoimisiún an 16 Meán Fómhair 2021, agus an Coiste Slándála Sláinte, ECDC, EMA agus gníomhaireachtaí agus comhlachtaí ábhartha eile de chuid an Aontais, comhordú agus comhoibriú a dhéanamh i ndáil leis an ullmhacht agus an fhreagairt sin.
In order to increase the effectiveness of the preparedness for and response to serious cross-border threats to health, the Commission including, where relevant, the Health Emergency Preparedness and Response Authority (HERA) established as a Commission service by Commission Decision of 16 September 2021, and the HSC, the ECDC, EMA and other relevant Union agencies and bodies should coordinate and cooperate in relation to such preparedness and response.
Ina theannta sin, ba cheart idirphlé rialta idir an Coiste Slándála Sláinte agus comhlachtaí ábhartha na Comhairle a threisiú chun a áirithiú go ndéanfar obair leantach an Choiste Slándála Sláinte ar an leibhéal náisiúnta ar bhealach níos fearr.
In addition, regular dialogue between the HSC and relevant Council bodies should be reinforced in order to ensure better follow-up of the HSC's work at national level.
malartú slán faisnéise idir an Coimisiún, na Ballstáit, go háirithe na húdaráis inniúla nó na comhlachtaí ainmnithe atá freagrach ar an leibhéal náisiúnta, an Coiste Slándála Sláinte agus gníomhaireachtaí nó comhlachtaí ábhartha an Aontais;
the secure exchange of information between the Commission, the Member States, in particular the competent authorities or designated bodies responsible at national level, the HSC and the relevant Union agencies or bodies;
Agus faisnéis rúnaicmithe a tharchuirtear de bhun mhír 1 á fáil, déanfaidh an Coimisiún, ECDC agus an Coiste Slándála Sláinte na rialacha maidir le slándáil i ndáil le faisnéis rúnaicmithe an Aontais Eorpaigh a chosaint, a leagtar síos i gCinntí (AE, Euratom) 2015/443 agus (AE, Euratom) 2015/444 ón gCoimisiún, a chur i bhfeidhm.
When receiving classified information transmitted pursuant to paragraph 1, the Commission, the ECDC and the HSC shall apply the rules on security regarding the protection of European Union classified information, laid down in Commission Decisions (EU, Euratom) 2015/443 and (EU, Euratom) 2015/444.
Comhordóidh an Coiste Slándála Sláinte freisin, i gcás inarb ábhartha, an fhreagairt ar éigeandálaí sláinte poiblí leis an mBord um Ghéarchéim Shláinte, i gcás ina suitear í i gcomhréir le Rialachán (AE) 2022/2372, agus rannchuideoidh sé dá réir sin le comhordú agus malartú faisnéise laistigh den chomhlacht sin.
The HSC shall also coordinate, where relevant, response to public health emergencies with the Health Crisis Board, where it is established in accordance with Regulation (EU) 2022/2372, and contribute accordingly to the coordination and information exchange within that body.
Le linn éigeandáil sláinte, an ionchorpraítear ionadaí Coiste Slándála Sláinte do Bhallstáit i struchtúir chomhordúcháin ar an leibhéal náisiúnta, go háirithe chun tacú leis an sreabhadh faisnéise idir do Bhallstát agus an Coiste Slándála Sláinte?
During a health emergency, is your Member State’s HSC representative incorporated into national level coordination structures, notably to support the flow of information between your Member State and the HSC?